1. Yang Long, Zhengze Lu, Ling Mei, Man Li, Kebai Ren, Xuhui Wang, Jiajing Tang, Zhirong Zhang, and Qin He*. Enhanced Melanoma-Targeted Therapy by “Fru-Blocked” Phenyboronic Acid-Modified Multiphase Antimetastatic Micellar Nanoparticles. Advanced Science, 2018, 5(11), 1800229. IF=12.441
2. Xingli Cun, Man Li, Shuying Wang, Yifei Wang, Jialing Wang, Zhengze Lu, Ruixin Yang, Xian Tang, Zhirong Zhang and Qin He*. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration. Nanoscale, 2018, 10, 9935–9948. IF =7.233
3. Zhengze Lu, Yang Long, Xingli Cun, Xuhui Wang, Jianping Li, Ling Mei, Yiliang Yang, Man Li, Zhirong Zhang and Qin He*. A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy. Nanoscale, 2018, 10, 9957–9970. IF =7.233
4. Man Li, Kairong Shi, Xian Tang, Jiaojie Wei, Xingli Cun, Xiaoxiao Chen, Qianwen Yu, Zhirong Zhang, Qin He⁎. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma. European Journal of Pharmaceutical Sciences, 124 (2018) 240–248. IF=3.466
5. Man Li, Kairong Shi, Xian Tang, , Jiaojie Wei, , Xingli Cun, Yang Long, Zhirong Zhang , Qin He*. Synergistic tumor microenvironment targeting and blood–brain barrier penetration via a pH-responsive dual-ligand strategy for enhanced breast cancer and brain metastasis therapy. Nanomedicine: Nanotechnology, Biology, and Medicine, 14 (2018) 1833–1843. IF=6.5
6. Man Li, Yuting Yang, Jiaojie Wei, Xingli Cun, Zhengze Lu, Yue Qiu, Zhirong Zhang, Qin He*. Enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8+ T cells. Nanomedicine: Nanotechnology, Biology, and Medicine, 14 (2018) 2541–2550. IF=6.5
7. Ling Mei, Yayuan Liu, Jingdong Rao, Xian Tang, Man Li, Zhirong Zhang and Qin He*. Enhanced Tumor Retention Effect by Click Chemistry for Improved Cancer Immunochemotherapy. ACS Appl. Mater. Interfaces 2018, 10, 17582−17593. IF=8.097
8. Ling Mei, Jingdong Rao, Yayuan Liu, Man Li, Zhirong Zhang, Qin He*. Effective treatment of the primary tumor and lymph node metastasis by polymeric micelles with variable particle sizes. Journal of Controlled Release, 2018, 292, 28, 67-77. IF=7.877
9. Sheng Yin, Chunyu Xia, Yashi Wang, Dandan Wan, Jingdong Rao, Xian Tang, Jiaojie Wei, Xuhui Wang, Man Li, Zhirong Zhang, Ji Liu⁎, Qin He*. Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways. Journal of Controlled Release 288 (2018) 148–160. IF=7.877
10. Qianwen Yu, Yue Qiu, Xuhui Wang, Jiajing Tang, Yayuan Liu, Ling Mei, Man Li, Ming Yang, Li Tang, Huile Gao, Zhirong Zhang, Wenming Xu*, Qin He*. Efficient siRNA transfer to knockdown a placenta specific lncRNA using RGD-modified nano-liposome: A new preeclampsia-like mouse model. International Journal of Pharmaceutics 546 (2018) 115–124. IF=3.862
11. Yue Qiu, Qianwen Yu, Yayuan Liu, Jiajing Tang, Xuhui Wang, Zhengze Lu, Zhuping Xu*, Qin He*. Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy. Pharm Res (2018) 35: 130. IF=3.335
12. Xuhui Wang, Yue Qiu, Qianwen Yu, Hui Li, Xiaoxiao Chen, Man Li, Yang Long, Yayuan Liu, Libao Lu, Jiajing Tang, Zhirong Zhang, Qin He*. Enhanced glioma therapy by synergistic inhibition of autophagy and tyrosine kinase activity. International Journal of Pharmaceutics 536 (2018) 1–10. IF=3.862
13. Yang Wang, Sheng Yin, Li Zhang, Kairong Shi, Jiajing Tang, Zhirong Zhang, Qin He*. A tumor-activatable particle with antimetastatic potential in breast cancer via inhibiting the autophagy-dependent disassembly of focal adhesion. Biomaterials 168 (2018) 1-9. IF=8.806
您当前位置： 